Cannabis use and sensorimotor gating in patients with schizophrenia and healthy controls

Human Psychopharmacology

Volumn 26, Issue 6, 2011, Pages 373-385

  Scholes Balog, Kirsty E ^a,b   Martin Iverson, Mathew T ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b GRAYLANDS HOSPITAL   (Australia)

Author keywords

cannabis; prepulse inhibition; schizophrenia; sensorimotor gating

Indexed keywords

CANNABIS;

ADULT; ARTICLE; ATTENTION; AUDITORY STIMULATION; CANNABIS SMOKING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MENTAL PATIENT; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREPULSE INHIBITION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REFLEX; SCHIZOPHRENIA; SENSORY GATING; STARTLE REFLEX; STIMULUS RESPONSE;

ACOUSTIC STIMULATION; ADULT; ATTENTION; CASE-CONTROL STUDIES; DRUG EFFECTS; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; PHYSIOLOGY; PHYSIOPATHOLOGY; PSYCHOLOGY; SCHIZOPHRENIA; SENSORY GATING; STARTLE REACTION; YOUNG ADULT;

EID: 80052268375     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1217     Document Type: Article

References (31)

1. Braff D, Geyer M,. 1990. Sensorimotor gating and schizophrenia: human and animal model studies. Arch Gen Psychiatry 47: 181-188. (Pubitemid 20058094)
2. Braff D, Geyer M, Swerdlow N,. 2001. Human studies of prepulse inhibition of startle: normal subjects, patient groups, pharmacological studies. Psychopharmacology (Berl) 156: 234-258. (Pubitemid 32705488)
3. Castle DJ, Jablensky A, McGrath JJ, et al,. 2006. The diagnostic interview for psychoses (DIP): development, reliability and applications. Psychol Med 36: 69-80. (Pubitemid 41825347)
4. Coulston CM, Perdices M, Tennant CC,. 2007. The neuropsychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res 96: 169-184. (Pubitemid 47494647)
5. Dawson M, Hazlett E, Filion D, Nuechterlein K, Schell A,. 1993. Attention and schizophrenia: impaired modulation of the startle reflex. J Abnorm Psychol 102: 633-641. (Pubitemid 23333506)
6. Dawson M, Schell A, Hazlett E, Nuechterlein K, Filion D,. 2000. On the clinical and cognitive meaning of impaired sensorimotor gating in schizophrenia. Psychiatry Res 96: 187-197.
7. Degenhardt L, Hall W,. 2006. Is cannabis use a contributory cause of psychosis. Can J Psychiatry 51: 556-565. (Pubitemid 44338229)
8. D'Souza DC, Perry E, MacDougall L, et al,. 2004. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 29: 1558-1572. (Pubitemid 38982249)
9. Duncan E, Madonick S, Charkravorty S, et al,. 2001. Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology (Berl) 156: 266-272. (Pubitemid 32702217)
10. Fowler IL, Carr VJ, Carter NT, Lewin TJ,. 1998. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 24: 443-455. (Pubitemid 28378229)
11. Graham F,. 1975. The more or less startling effects of weak prestimulation. Psychophysiology 12: 238-248.
12. Hamm A, Weike A, Schupp H,. 2001. The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues. Psychopharmacology (Berl) 156: 259-265. (Pubitemid 32702216)
13. Haney M, Ward AS, Comer SD, Foltin RW, Fischman MW,. 1999. Abstinence symptoms following oral THC administration to humans. Psychopharmacology (Berl) 141: 385-394. (Pubitemid 29190007)
14. Kedzior KK, Martin-Iverson M,. 2007. Attention-dependent reduction in prepulse inhibition of the startle reflex in cannabis users and schizophrenia patients-a pilot study. Eur J Pharmacol 560: 176-182. (Pubitemid 46341313)
15. Kedzior KK, Badcock JC, Martin-Iverson MT,. 2006. Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients. Subst Use Misuse 41: 743-750.
16. Kumari V, Das M, Zachariah E, Ettinger U, Sharma T,. 2005. Reduced prepulse inhibition in unaffected siblings of schizophrenia patients. Psychophysiology 42: 588-94. (Pubitemid 43942839)
17. Nagai H, Egashira N, Sano K, et al,. 2006. Antipsychotics improve [Delta]9-tetrahydrocannabinol-induced impairment of the prepulse inhibition of the startle reflex in mice. Pharmacol Biochem Behav 84: 330-336. (Pubitemid 44107489)
18. Newell KA, Deng C, Huang XF,. 2006. Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res 172: 556-560. (Pubitemid 43989359)
19. Patton GC, Coffey C, Carlin JP, Degenhardt L, Lynskey M, Hall W,. 2002. Cannabis use and mental health in young people: cohort study. Br Med J 325: 1195-1198. (Pubitemid 35398781)
20. Pope HG, Yurgelun-Todd D,. 1996. The residual cognitive effects of heavy marijuana use in college students. J Am Med Assoc 275: 521-527. (Pubitemid 26061426)
21. Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D,. 2001. Neuropsychological performance in longterm cannabis users. Arch Gen Psychiatry 58: 909-915. (Pubitemid 32937912)
22. Regier DA, Farmer ME, Rae, DS, et al,. 1990. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. J Am Med Assoc 264: 2511-2518.
23. Scholes KE, Martin-Iverson M,. 2009a. Altered prepulse inhibition in chronic cannabis users is secondary to sustain attention deficits. Psychopharmacology (Berl) 207: 469-484.
24. Scholes KE, Martin-Iverson M,. 2009b. Relationships between prepulse inhibition and cognition are mediated by attentional processes. Behav Brain Res 205: 456-467.
25. Scholes KE, Martin-Iverson MT,. 2010. Disturbed prepulse inhibition in patients with schizophrenia is consequential to dysfunction of selective attention. Psychophysiology 47: 223-235.
26. Schwarcz G, Karajgi B, McCarthy R,. 2009. Synthetic delta-9- tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia. J Clin Psychopharmacol 29: 255-258.
27. Sevy S, Burdick KE, Visweswaraiah H, et al,. 2007. Iowa Gambling Task in schizophrenia: a review and new data in patients with schizophrenia and co-occurring cannabis use disorders. Schizophr Res 92: 74-84. (Pubitemid 46561220)
28. Sheehan DV, Lecrubier Y, Sheehan H, et al,. 1998. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Supplement 20): 22-57.
29. Solowij N,. 1998. Cannabis and Cognitive Functioning. Cambridge University Press: Cambridge.
30. Stoddart CW, Noonan J, Martin-Iverson MT,. 2008. Stimulus quality affects expression of the acoustic startle response and prepulse inhibition in mice. Behav Neurosci 122: 516-526. (Pubitemid 351787831)
31. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G,. 2002. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. Br Med J 325: 1195-1212.